Analystreport

Array Biopharma Inc (NASDAQ: ARRY) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.

Array Technologies, Inc.  (ARRY) 
Last array technologies, inc. earnings: 5/7 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.arraybiopharma.com/investor-overview